IPO Mania Fizzles in Hong Kong with the disappearance of Mega Pops from the first day

Hong Kong Stock Exchange as LSE bid for Bourse hit by further setbacks

Photographer: Paul Yeung / Bloomberg

The days of big first-day pop in the Hong Kong initial public offering frenzy may be coming to an end.

Even with the pandemic spreading most of 2020, the initial public offerings of the Chinese offshore city and the new listings were in high demand by institutional and small investors. With most of the new stock sales posting big gains on the first day of trading, the investor’s euphoria was justified.

That was before. The investor’s largely winning game last year of piling up on IPOs and leaving after debut is no longer a straight hit: 31% of the thirteen IPOs that raised more than $ 100 million recorded losses on the first day of this year, almost the double the 17% in 2020. A median The change from the first day showed gains of 2.1% in 2021, from 5.7% last year, according to data compiled by Bloomberg.

The volatility caused by the high turnover in previously unloved stocks, sensitive to the economic fluctuations of highly valued technology and healthcare companies, is to blame, according to investors. Others also pointed out concerns about policy tightening in China, as a burden on investors’ risk appetite for new stocks.

Hong Kong's Hang Seng Tech Index had its biggest sale in a year this month

“Most IPOs performed very, very strongly last year, but I am not expecting that kind of movement this year,” said Joohee An, a fund manager at Mirae Asset Global Invest (HK) Ltd. Investors will be ” more prudent, “as market liquidity” will not be as plentiful as it used to be, “he added.

Hong Kong bankers work 24 hours a day as IPOs, increased SPACs (1)

Unstable performance

To be clear, listings by Kuaishou Technology and New Horizon Health Ltd. still performed exceptionally well in February, with stocks more than doubling on the first day.

But the post-listing warm performance is increasing. Chinese household insecticide company Cheerwin Group Ltd. plunged up to 20% on its first trading day last week. The biopharmaceutical company SciClone Pharmaceuticals Holdings Ltd. ended its debut on March 3 stable and is now trading 8.6% below its offer price.

The wave of secondary listing of Chinese companies listed in the United States has not always had brilliant debuts in Hong Kong. Autohome Inc., a Chinese online car sales website with its primary listing in New York, has closed its Hong Kong opens on Monday with a modest 2% increase.

.Source